NovaBay Pharmaceuticals, Inc. Total non-current assets

Total non-current assets of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total non-current assets growth rates and interactive chart. The sum of all non-current or long-term assets.


Highlights and Quick Summary

  • Total non-current assets for the quarter ending June 30, 2022 was $12.1 Million (a -1.88% decrease compared to previous quarter)
  • Year-over-year quarterly Total non-current assets increased by 1528.71%
  • Annual Total non-current assets for 2021 was $10.8 Million (a 985.14% increase from previous year)
  • Annual Total non-current assets for 2020 was $996 Thousand (a -45.84% decrease from previous year)
  • Annual Total non-current assets for 2019 was $1.84 Million (a 144.22% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total non-current assets of NovaBay Pharmaceuticals, Inc.

Most recent Total non-current assetsof NBY including historical data for past 10 years.

Interactive Chart of Total non-current assets of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Total non-current assets for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $12.09 $12.32
2021 $10.81 $0.74 $0.83 $0.93 $10.81
2020 $1.0 $1.07 $1.36 $1.6 $1.0
2019 $1.84 $2.11 $2.37 $2.61 $1.84
2018 $0.75 $0.84 $0.93 $1.03 $0.75
2017 $1.08 $1.12 $1.1 $1.15 $1.08
2016 $0.91 $0.72 $0.43 $0.37 $0.91
2015 $0.55 $0.51 $0.53 $0.56 $0.55
2014 $0.59 $0.63 $0.63 $0.8 $0.59
2013 $0.86 $0.76 $0.84 $0.88 $0.86
2012 $0.95 $1.15 $1.19 $1.25 $0.95
2011 $1.41 $1.52 $1.41

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology